| J0897 | Injection, denosumab, 1 mg | 28,380 | $20 | $510.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 8,010 | $30 | $208.3K |
| J3262 | Injection, tocilizumab, 1 mg | 36,480 | $10 | $182.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,410 | $90 | $124.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 8,000 | $10 | $88K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 10,500 | $10 | $84K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 250 | $130 | $33.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $100 | $33.3K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 600 | $60 | $32.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 140 | $120 | $16.5K |